Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
about
Malaria 2017: Update on the Clinical Literature and Management.Primaquine-thiazolidinones block malaria transmission and development of the liver exoerythrocytic forms.Differential activity of methylene blue against erythrocytic and hepatic stages of Plasmodium.Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia.
P2860
Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Tafenoquine and its potential ...... malaria: the evidence to date
@ast
Tafenoquine and its potential ...... malaria: the evidence to date
@en
Tafenoquine and its potential ...... malaria: the evidence to date
@nl
type
label
Tafenoquine and its potential ...... malaria: the evidence to date
@ast
Tafenoquine and its potential ...... malaria: the evidence to date
@en
Tafenoquine and its potential ...... malaria: the evidence to date
@nl
prefLabel
Tafenoquine and its potential ...... malaria: the evidence to date
@ast
Tafenoquine and its potential ...... malaria: the evidence to date
@en
Tafenoquine and its potential ...... malaria: the evidence to date
@nl
P2093
P2860
P921
P3181
P356
P1476
Tafenoquine and its potential ...... malaria: the evidence to date
@en
P2093
Dawit A Ejigu
Wondmagegn T Tadesse
Yehenew A Ebstie
P2860
P304
P3181
P356
10.2147/DDDT.S61443
P407
P5008
P577
2016-07-26T00:00:00Z